CLINICAL_TRIALS
research
· 2025-07-04
Clinical Trial Update: PSMA-Guided Ablation of the Prostate [Phase 2]
Summary
This ClinicalTrials.gov entry describes a Phase 2 study evaluating PSMA-guided ablation for localized prostate cancer. The trial is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Prostate Cancer, Localized Prostate Carcinoma | Phase 2 | Status: RECRUITING